Translational fidelity screens in mammalian cells reveal eIF3 and eIF4G2 as regulators of start codon selectivity
Nucleic Acids Research · 2023
DOI: 10.1093/nar/gkad329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Richard She und 2 weiteren Autor:innen. Beteiligte Einrichtung: Whitehead Institute for Biomedical Research, Cambridge, MA, USA. Hauptthemen laut MEDLINE: Eukaryotic Initiation Factor-3, RNA, Guide, CRISPR-Cas Systems. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Howard Hughes Medical Institute.
Abstract (Originalsprache)
The translation initiation machinery and the ribosome orchestrate a highly dynamic scanning process to distinguish proper start codons from surrounding nucleotide sequences. Here, we performed genome-wide CRISPRi screens in human K562 cells to systematically identify modulators of the frequency of translation initiation at near-cognate start codons. We observed that depletion of any eIF3 core subunit promoted near-cognate start codon usage, though sensitivity thresholds of each subunit to sgRNA-mediated depletion varied considerably. Double sgRNA depletion experiments suggested that enhanced near-cognate usage in eIF3D depleted cells required canonical eIF4E cap-binding and was not driven by eIF2A or eIF2D-dependent leucine tRNA initiation. We further characterized the effects of eIF3D depletion and found that the N-terminus of eIF3D was strictly required for accurate start codon selection, whereas disruption of the cap-binding properties of eIF3D had no effect. Lastly, depletion of eIF3D activated TNFα signaling via NF-κB and the interferon gamma response. Similar transcriptional profiles were observed upon knockdown of eIF1A and eIF4G2, which also promoted near-cognate start codon usage, suggesting that enhanced near-cognate usage could potentially contribute to NF-κB activation. Our study thus provides new avenues to study the mechanisms and consequences of alternative start codon usage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
- Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
- David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology; Cambridge, MA 02142, USA.
- Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.
ORCID-Profile: Richard She, Jingchuan Luo
Förderung
- Howard Hughes Medical Institute
Zitieren
APA
She, R., Luo, J., & Weissman, J. S. (2023). Translational fidelity screens in mammalian cells reveal eIF3 and eIF4G2 as regulators of start codon selectivity. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad329
Vancouver
She R, Luo J, Weissman JS. Translational fidelity screens in mammalian cells reveal eIF3 and eIF4G2 as regulators of start codon selectivity. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad329
BibTeX
@article{She2023,
author = {She, Richard and Luo, Jingchuan and Weissman, Jonathan S},
title = {Translational fidelity screens in mammalian cells reveal eIF3 and eIF4G2 as regulators of start codon selectivity},
journal = {Nucleic Acids Research},
year = {2023},
doi = {10.1093/nar/gkad329}
}
EUVIMED